Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital

Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital

Authors

  • Elif Çalışkan Gazi University Faculty of Medicine
  • Yusuf Can Edek Gazi University Faculty of Medicine
  • Nuray Keskin Yenimahalle Training and Research Hospital
  • Petek Üstün Gazi University Faculty of Medicine
  • Esra Adışen Gazi University Faculty of Medicine

Keywords:

psoriasis, Palmoplantar psoriasis, Keratoderma, Quality of life

Abstract

Introduction: Psoriasis is an inflammatory skin disease characterized by erythematous, scaly, and well-demarcated pruritic plaques on the extensor areas of the extremities. Psoriasis is one of the most common dermatological diseases in the geriatric population.

Objective: The aim of this investigation is to evaluate the demographic data, clinical characteristics, and treatment responses of the geriatric population (≥60 with psoriasis at our hospital.

Methods: In this study, we examined 221 geriatric patients diagnosed with psoriasis. We evaluated patients in 2 groups: early-onset (<60 years) and elderly-onset (≥60 years).

Results: In our study, 50.7% of the patients were female, the average age was 65.9 years., and 76.4% of the patients were considered early-onset. There was no significant difference in terms of the initial body areas affected by the disease between the early-onset and elderly-onset groups; 45.7% of patients had nail psoriasis, while 27.1% had psoriatic arthritis. Nail involvement (p = 0.021) and the presence of psoriatic arthritis (p = 0.011) were more common in the early-onset group. Systemic treatment was predominantly initiated as the first treatment agent in the elderly-onset group (p = 0.014). Patients in the early-onset group received more cyclosporine treatment than the others (p=0.01).

Conclusions: The geriatric population is associated with multiple comorbidities and polypharmacy, highlighting the importance of evaluating patients' medications and comorbidities when selecting a treatment agent for psoriasis.

References

Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082. Published 2016 Nov 24. DOI:10.1038/nrdp.2016.82

Nair PA, Badri T. Psoriasis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 3, 2023.

Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243-258. DOI:10.1111/bjd.19169

Tseng IL, Yang CC, Lai EC, Lee CN. Psoriasis in the geriatric population: A retrospective study in Asians. J Dermatol. 2021;48(6):818-824. DOI:10.1111/1346-8138.15737

Balato, N., Patruno, C., Napolitano, M. et al. Managing Moderate-to-Severe Psoriasis in the Elderly. Drugs Aging 31, 233–238 (2014). DOI:10.1007/s40266-014-0156-6

Chen C, Che K, Guo Y, Huang Q, Hu X, Yu B. Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis [published online ahead of print, 2023 Jun 22]. J Dermatol. 2023;10.1111/1346-8138.16856. DOI:10.1111/1346-8138.16856

Yamazaki F. Psoriasis: Comorbidities. J Dermatol.2021;48(6):732-740. DOI:10.1111/1346-8138.15840

Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76(3):377-390. DOI:10.1016/j.jaad.2016.07.064

Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front Immunol. 2022;13:880201. Published 2022 Jun 10. DOI:10.3389/fimmu.2022.880201

Reid C, Griffiths CEM. Psoriasis and Treatment: Past, Present and Future Aspects. Acta Derm Venereol. 2020;100(3):adv00032. Published 2020 Jan 30. DOI:10.2340/00015555-3386

van Winden MEC, ter Haar ELM, Groenewoud HMM, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups. Acta Derm Venereol. 2020;100(14):adv00215. Published 2020 Jul 28. DOI:10.2340/00015555-3569

Megna M, Camela E, Battista T, et al. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opin Drug Saf. 2023;22(1):43-58. DOI:10.1080/14740338.2023.2173171

Piaserico S, Conti A, Lo Console F, et al. Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol. 2014;94(3):293-297. DOI:10.2340/00015555-1719

Trettel A, Spehr C, Körber A, Augustin M. The impact of age on psoriasis health care in Germany. J Eur Acad Dermatol Venereol. 2017;31(5):870-875. DOI:10.1111/jdv.14115

Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20(6):1475. Published 2019 Mar 23. DOI:10.3390/ijms20061475

Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11(1):43-49. DOI:10.1038/nm1162

Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019;20(18):4347. Published 2019 Sep 5. doi:10.3390/ijms20184347

Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165-1172. DOI:10.1111/ijd.14032

Zhou S, Yao Z. Roles of Infection in Psoriasis. Int J Mol Sci. 2022;23(13):6955. Published 2022 Jun 23. DOI:10.3390/ijms23136955

Weatherhead SC, Farr PM, Jamieson D, et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol. 2011;131(9):1916-1926. DOI:10.1038/jid.2011.134

Zaiem A, Daldoul M, Badri T, et al. De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine. Therapie. 2023;78(4):446-447. DOI:10.1016/j.therap.2022.07.008

Adışen E, Uzun S, Erduran F, Gürer MA. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. An Bras Dermatol. 2018;93(2):205-211. DOI:10.1590/abd1806-4841.20186168

Fatema F, Ghoshal L, Saha A, Agarwal S, Bandyopadhyay D. Early-Onset Versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center. Indian J Dermatol. 2021;66(6):705. DOI:10.4103/ijd.ijd_45_21

Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol. 2012;51(1):53-58. DOI:10.1111/j.1365-4632.2011.04979.x

Downloads

Published

2025-01-29

How to Cite

1.
Çalışkan E, Edek YC, Keskin N, Üstün P, Adışen E. Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital. Dermatol Pract Concept. 2025;15(1):4511 . doi:10.5826/dpc.1501a4511

Share